Dr. Matthew Dallos, MD
Claim this profileColumbia University Medical Center (Cumc)
Studies Prostate Cancer
Studies Skin Cancer
9 reported clinical trials
19 drugs studied
Affiliated Hospitals
Clinical Trials Matthew Dallos, MD is currently running
2141-V11 Antibody
for Prostate Cancer
The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11 works by activating the immune system to find and kill cancer cells. Researchers will look at whether this treatment approach is able to completely get rid of cancer in participants, and they will check for the presence of minimal residual disease (MRD) in participants. MRD is a small number of cancer cells that can be detected in the body after treatment.
Recruiting1 award Phase 2
Canakinumab + Spartalizumab
for Renal Cell Carcinoma
Primary Objective: * To confirm the safety and feasibility of canakinumab and spartalizumab (PDR-001) administered using a standard dose / schedule in the neo-adjuvant setting in renal cell carcinoma Secondary Objectives: * To assess the immune response to combination canakinumab and spartalizumab * To assess anti-tumor activity as measured by pathologic downstaging
Recruiting1 award Phase < 111 criteria
More about Matthew Dallos, MD
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Matthew Dallos, MD has experience with
- BMS-986253
- Nivolumab
- Degarelix
- 2141-V11
- Abiraterone Acetate
- Apalutamide
Breakdown of trials Matthew Dallos, MD has run
Prostate Cancer
Skin Cancer
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Dallos, MD specialize in?
Matthew Dallos, MD focuses on Prostate Cancer and Skin Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Matthew Dallos, MD currently recruiting for clinical trials?
Yes, Matthew Dallos, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Matthew Dallos, MD has studied deeply?
Yes, Matthew Dallos, MD has studied treatments such as BMS-986253, Nivolumab, Degarelix.
What is the best way to schedule an appointment with Matthew Dallos, MD?
Apply for one of the trials that Matthew Dallos, MD is conducting.
What is the office address of Matthew Dallos, MD?
The office of Matthew Dallos, MD is located at: Columbia University Medical Center (Cumc), New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center (Cumc).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.